Supernus amends 2018 merger agreement milestone terms with Reich Consulting

SUPERNUS PHARMACEUTICALS, INC.

First Amendment to Merger Agreement dated September 12, 2018, entered on January 22, 2026.
Amendment adjusts timing and payment terms for certain milestones under the original deal.
Exhibit 10.1 filed with limited redactions for non-material, competitively harmful details.
No financial figures or revised milestone amounts disclosed in the filing.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

SUPERNUS PHARMACEUTICALS, INC. amended First Amendment with Reich Consulting Group, Inc. as the Securityholder Representative (effective 2026-01-22).

Action: amendment
Agreement: merger
Counterparty: Reich Consulting Group, Inc. as the Securityholder Representative
Effective: 2026-01-22

Exact text from the filing

On January 22, 2026, Supernus Pharmaceuticals, Inc. (the “Company”) entered into a First Amendment (the “Amendment”) to the Agreement and Plan of Merger dated September 12, 2018 (the “Merger Agreement”), with Reich Consulting Group, Inc. as the Securityholder Representative.

View on SEC.gov

291 material agreements filed in the last 30 days. Browse all material agreements →

SUPERNUS PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001628280-26-003907

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.